Carol Suh

ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin.

Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation.

HIBio, Inc. is a clinical immunology company that leverages human genetic and immunological insights to deliver targeted therapies to patients with severe immune-mediated diseases. The company is based in South San Francisco, CA. HIBio is excited to work as part of a collaborative team. HIBio was founded by Tim Behrens and Travis Murdoch, with Travis Murdoch serving as the CEO since incorporation.

Orbital Therapeutics, Inc. is a company based in Cambridge, MA that aims to enhance health by utilizing RNA-based medicines to treat human diseases in innovative ways. The company is building a platform that combines RNA technology delivery methods, data science, and automation to develop a portfolio of medicines focused on vaccines, immunomodulation, protein replacement, and regenerative medicine. The company was founded by Drew Weissman, John M. Maraganore, Kristina M. Burow, Ravindra Majeti, Giuseppe Ciaramella, Eugene W. Yeo, Howard Y. Chang, and Carol Suh, with Giuseppe Ciaramella serving as the CEO since incorporation.

Metrodora SL is an investment holding Spanish company. The private company is based in Madrid, Spain. and has subsidiaries in Spain. The company was founded in 2021. The CEO is Héctor Martínez.

Trinity Partners LLC engages in provision of financial advisory services. Its services include strategic planning, and tactical and operational planning. The firm?s practice areas include corporate strategy, pipeline and portfolio optimization, licensing and acquisitions, brand and launch planning, market analysis, and advanced analytics. The company was founded by John E. Corcoran in 1996 and is headquartered in Waltham, MA.

Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA.